Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Journal of Oral Biology and Craniofacial Research|December 11, 2023
Alteration in PNMA1 expression is associated with poor prognosis and tumor immune infiltration in head and neck squamous cell carcinomaDakshitha Sankar, Balachander Kannan, Vijayashree Priyadharsini Jayaseelan, et al.
Journal of Stomatology, Oral and Maxillofacial Surgery|July 12, 2023
Dysregulated m6A methylation modification is associated with human peri-implantitis - A pilot studyHarini Sri Krishnamoorthy, Balachander Kannan, Dhanraj Ganapathy, et al.
Journal of Stomatology, Oral and Maxillofacial Surgery|September 4, 2023
Prognostic and clinicopathological significance of MRC2 expression in head and neck squamous cell carcinomaKarpaka Vinayakam Gopalakrishnan, Balachander Kannan, Chandra Pandi, et al.
Molecular Biology Reports|August 9, 2024
Biallelic loss-of-function variations in BTD cause profound biotinidase deficiency in an Indian patientBalachander Kannan, Vijayashree Priyadharsini Jayaseelan, Paramasivam Arumugam, et al.
Journal of Oral Biology and Craniofacial Research|July 25, 2024
Overexpression of insulin-like growth factor-2 mRNA-binding protein 1 is associated with periodontal diseaseBurra Anand Deepika, Jaiganesh Ramamurthy, Balachander Kannan, et al.
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology|December 28, 2023
EXT2: a novel prognostic and predictive biomarker for head and neck squamous cell carcinomaAngel Jenifer Arul Selvan, Balachander Kannan, Chandra Pandi, et al.
Clinical Oral Investigations|October 20, 2023
RFC3 serves as a novel prognostic biomarker and target for head and neck squamous cell carcinomaKeerthana Reddy Avs, Chandra Pandi, Balachander Kannan, et al.
Archives of Oral Biology|September 19, 2024
Dysregulation of a novel m6A regulator YWHAG is correlated with metastasis and poor prognosis in oral squamous cell carcinoma - A cross-sectional studyRithanyaa Ramesh Kumar, Balachander Kannan, Chandra Pandi, et al.
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology|May 30, 2024
Aberrant expression of VASP serves as a potential prognostic biomarker and therapeutic target for oral squamous cell carcinomaKarpakavinayakam Gopalakrishnan, Balachander Kannan, Chandra Pandi, et al.
Pageof 3